GSK to start three-year plan to save cash, takes £1.33B hit on cough trial failure
GSK said Tuesday it is rolling out a three-year restructuring program designed to cut costs and streamline its focus on key advanced assets. The UK drugmaker said in its second-quarter earnings release that its plan ...
Luke Miels, GSK CEO July 28, 2026 07:35 AM EDT Pharma GSK to start three-year plan to save cash, takes £1.33B hit on cough trial failure Ayisha Sharma News Reporter GSK said Tuesday it is rolling out a three-year restructuring program designed to cut costs and streamline its focus on key advanced assets. The UK … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that